DE3381850D1 - Pharmazeutische zusammensetzung. - Google Patents

Pharmazeutische zusammensetzung.

Info

Publication number
DE3381850D1
DE3381850D1 DE8383112757T DE3381850T DE3381850D1 DE 3381850 D1 DE3381850 D1 DE 3381850D1 DE 8383112757 T DE8383112757 T DE 8383112757T DE 3381850 T DE3381850 T DE 3381850T DE 3381850 D1 DE3381850 D1 DE 3381850D1
Authority
DE
Germany
Prior art keywords
alkyl
chem
hydrogen
formula
ace
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8383112757T
Other languages
English (en)
Inventor
Robert Wayne Watkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE3381850D1 publication Critical patent/DE3381850D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DE8383112757T 1982-12-27 1983-12-19 Pharmazeutische zusammensetzung. Expired - Fee Related DE3381850D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45325782A 1982-12-27 1982-12-27

Publications (1)

Publication Number Publication Date
DE3381850D1 true DE3381850D1 (de) 1990-10-04

Family

ID=23799812

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383112757T Expired - Fee Related DE3381850D1 (de) 1982-12-27 1983-12-19 Pharmazeutische zusammensetzung.

Country Status (4)

Country Link
EP (1) EP0114333B1 (de)
JP (1) JPS59130816A (de)
AT (1) ATE55911T1 (de)
DE (1) DE3381850D1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3410732A1 (de) * 1984-03-23 1985-09-26 Hoechst Ag, 6230 Frankfurt Methode zur behandlung des glaukoms
US4885293A (en) * 1984-09-24 1989-12-05 Schering Corporation Antiglaucoma agents
WO1987000055A1 (en) * 1985-07-03 1987-01-15 Schering Corporation Antiglaucoma compositions
US4914090A (en) * 1985-11-01 1990-04-03 Schering Corporation Ophthalmic compositions
GB8626217D0 (en) * 1986-11-03 1986-12-03 Sandoz Ltd Pharmaceutical compositions
US5346887A (en) * 1987-10-06 1994-09-13 Abbott Laboratories Glaucoma treatment
US4927807A (en) * 1987-10-06 1990-05-22 Abbott Laboratories Glaucoma treatment
US5036051A (en) * 1987-10-06 1991-07-30 Abbott Laboratories Glaucoma treatment
US5059589A (en) * 1988-09-08 1991-10-22 Abbott Laboratories Glaucoma treatment
CA2005753A1 (en) * 1988-12-19 1990-06-19 Arthur A. Patchett Angiotensin converting enzyme inhibitors in the treatment of glaucoma
US5688770A (en) * 1989-12-14 1997-11-18 Schering Corporation Antiglaucoma compositions and methods
WO1999036062A1 (en) * 1998-01-16 1999-07-22 Alcon Laboratories, Inc. Topical administration of angiotensin-converting enzyme inhibitors
CZ20014516A3 (cs) 1999-06-16 2002-05-15 Rekik Elyes Ben Mohamed Raouf Neuroprotektivní a retinoprotektivní oftalmologické léčivo
FR2794975A1 (fr) * 1999-06-16 2000-12-22 Raouf Rekik Medicaments opthalmologiques neuro et retino-protecteurs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046889A (en) * 1976-02-13 1977-09-06 E. R. Squibb & Sons, Inc. Azetidine-2-carboxylic acid derivatives
EP0050800B2 (de) * 1980-10-23 1995-06-07 Schering Corporation Carboxyalkyl-Dipeptide, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US4442089A (en) * 1982-07-06 1984-04-10 E. R. Squibb & Sons, Inc. Method for treating glaucoma with topical or systemic ACE inhibitor compositions

Also Published As

Publication number Publication date
EP0114333A2 (de) 1984-08-01
JPS59130816A (ja) 1984-07-27
EP0114333B1 (de) 1990-08-29
EP0114333A3 (en) 1985-08-14
ATE55911T1 (de) 1990-09-15
JPS6225645B2 (de) 1987-06-04

Similar Documents

Publication Publication Date Title
ATE55911T1 (de) Pharmazeutische zusammensetzung.
AU540707B2 (en) N-methyl-3-(2methyl phenoxy)-o-phenylpropyl amine
FI932249A0 (fi) Dubbelverkande inhibitorer
WO1991019707A3 (en) Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
HK1000600A1 (en) Xanthine compounds
GR3035526T3 (en) Retroviral protease inhibitors.
DE69425804D1 (en) Phosphonsäurediesterderivate
HU9501801D0 (en) Lactame-compounds as pharmaceutical active component
AU4611589A (en) Enzyme-inhibiting amino acid derivatives, a process for the preparation thereof, agents containing these, and the use thereof.
GR3029428T3 (en) Novel bisoxadiazolidine derivative
IL119297A (en) 2,3-Dihydroxypropyl-2-(1-oxoalkyl) amino-2-deoxyglucopyranosides a process for their preparation and compositions containing them
AU6599186A (en) N-(6-(4-0-hydrxyphenyl-1,3-dioxan-cis-5-yl)hexenoyl) suphonamide derivatives
TW329388B (en) Intraocular irrigating solution
ZA942686B (en) Active compound from a sponge
AU4370489A (en) The use of oxidized polyamines, especially nn'-bis-(3- propionaldehyde)-1-4-diaminobutane (sperminedialdehyde) as immunosuppressive agents
AU5932786A (en) Benzotriazoles and use as bridging reagents for the coupling of aminoacids
CA1270833C (en) 2,5-PYRROLIDINEDIONE DERIVATIVES USEFUL AS ANTI-ARHYTMIZING AGENTS

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee